Metropolitan Life Insurance Company (MetLife)’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-24,784
| Closed | -$482K | – | 2545 |
|
|
2018
Q1 | $482K | Buy |
24,784
+512
| +2% | +$10K | 0.01% | 1302 |
|
|
2017
Q4 | $404K | Sell |
24,272
-27,673
| -53% | -$507K | 0.01% | 1421 |
|
|
2017
Q3 | $1.05M | Hold |
51,945
| – | – | 0.01% | 1216 |
|
|
2017
Q2 | $836K | Hold |
51,945
| – | – | 0.01% | 1354 |
|
|
2017
Q1 | $657K | Sell |
51,945
-1,167
| -2% | -$14.1K | ﹤0.01% | 1469 |
|
|
2016
Q4 | $704K | Hold |
53,112
| – | – | 0.01% | 1517 |
|
|
2016
Q3 | $1.26M | Hold |
53,112
| – | – | 0.01% | 1161 |
|
|
2016
Q2 | $1.53M | Buy |
53,112
+2,484
| +5% | +$81K | 0.01% | 1037 |
|
|
2016
Q1 | $1.62M | Hold |
50,628
| – | – | 0.01% | 969 |
|
|
2015
Q4 | $2.17M | Hold |
50,628
| – | – | 0.02% | 868 |
|
|
2015
Q3 | $1.78M | Sell |
50,628
-529
| -1% | -$23.8K | 0.01% | 953 |
|
|
2015
Q2 | $2.35M | Sell |
51,157
-2,855
| -5% | -$136K | 0.02% | 908 |
|
|
2015
Q1 | $2.53M | Sell |
54,012
-244
| -0.4% | -$9.71K | 0.02% | 811 |
|
|
2014
Q4 | $1.72M | Hold |
54,256
| – | – | 0.01% | 1027 |
|
|
2014
Q3 | $1.29M | Hold |
54,256
| – | – | 0.01% | 1131 |
|
|
2014
Q2 | $1.63M | Buy |
54,256
+307
| +0.6% | +$8.28K | 0.01% | 1086 |
|
|
2014
Q1 | $1.43M | Hold |
53,949
| – | – | 0.01% | 1128 |
|
|
2013
Q4 | $1.36M | Buy |
53,949
+44
| +0.1% | +$982 | 0.01% | 1157 |
|
|
2013
Q3 | $1.11M | Hold |
53,905
| – | – | 0.01% | 1227 |
|
|
2013
Q2 | $1.07M | Buy |
+53,905
| New | +$957K | 0.01% | 1188 |
|
Metropolitan Life Insurance Company (MetLife)'s IPXL Position: Q2 2018 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 24,784 shares — an estimated $482K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $2.53M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 24,784 Impax Laboratories, Inc. shares in Q2 2018, an estimated $482K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Impax Laboratories, Inc. position peaked at $2.53M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2018, filed 15 Aug 2018.